Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells invitro but have additive anti-myeloma activity invivo

Danielle N. Yarde, Rebecca A. Nace, Stephen J. Russell

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells invitro but have additive anti-myeloma activity invivo'. Together they form a unique fingerprint.

Medicine & Life Sciences